| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/24/1993 | EP0527764A1 Phosphonopeptides with collagenase inhibiting activity |
| 02/24/1993 | EP0527736A1 Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs. |
| 02/24/1993 | EP0419535A4 Platinum-polymer complexes and their use as antitumor agents |
| 02/23/1993 | US5189212 Used in estrogen replacement therapy like menopause, osteoporosis therapy, prevention of excessive hair growth of body and infertility |
| 02/23/1993 | US5189178 Preventing protein destruction |
| 02/23/1993 | US5189065 Administering the warm-blooded animals |
| 02/23/1993 | US5189055 Phenylpyrrolic compounds used as drugs, their preparation and application |
| 02/23/1993 | US5189050 Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder |
| 02/23/1993 | CA2076573A1 Benzodioxane derivatives |
| 02/22/1993 | CA2076479A1 Benzo ¬f| quinolinones |
| 02/22/1993 | CA2076431A1 Condensed pyrimidine derivative |
| 02/20/1993 | CA2076311A1 Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/18/1993 | WO1993003059A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 02/18/1993 | WO1993002708A1 Novel reagent for tumour imaging and therapy |
| 02/18/1993 | WO1993002556A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | WO1992019613A3 1,2-dithiole-3-thione derivative-based therapeutical compositions |
| 02/18/1993 | CA2113990A1 Cancer therapy utilizing malignant cells |
| 02/17/1993 | EP0527687A2 Novel arylethylamin derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/17/1993 | EP0527494A1 Compositon containing rhodacyanine dyes for treating cancer |
| 02/17/1993 | EP0527189A1 Novel cc-1065 analogs |
| 02/17/1993 | EP0527181A1 Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
| 02/17/1993 | CA2075678A1 Non-substrate inhibitors of farnesyl protein transferase |
| 02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
| 02/16/1993 | US5187077 Leukaemia inhibitory factor |
| 02/16/1993 | CA1313667C Indole alkaloid composition and their methods of use |
| 02/16/1993 | CA1313655C Cis-platinum complexes, a process for the preparation thereof, and pharmaceuticals containing these compounds |
| 02/10/1993 | WO1993002684A1 β-GLUCURONIDASE INHIBITOR |
| 02/10/1993 | EP0527069A1 Derivatives of pyrrolidine and thiazolidine, their preparation, and pharmaceutical compositions containing them |
| 02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
| 02/10/1993 | EP0527042A2 3-deoxy-mannosamine derivatives and process for their preparation |
| 02/10/1993 | EP0526888A2 Monoclonal antibody reactive with human pancreas cancer tissue |
| 02/10/1993 | EP0526700A2 Drug-containing protein-bonded liposome |
| 02/10/1993 | EP0526608A1 Therapeutic agents for the treatment of multidrug resistance to cancers. |
| 02/10/1993 | CN1068819A Selective aromatase inhibiting 4(5)-imidazoles |
| 02/10/1993 | CN1068744A Asialoglycoprotein-conjugated medicinal agent |
| 02/10/1993 | CN1019889C Process for preparing urea derivatives |
| 02/10/1993 | CA2093442A1 B-glucuronidase inhibitor |
| 02/09/1993 | US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| 02/09/1993 | US5185352 Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 02/09/1993 | US5185331 Triazolobenzodiazepines |
| 02/09/1993 | US5185254 Gene family of tumor-associated antigens |
| 02/09/1993 | CA2074701A1 Cribrostatins 1 and 2 |
| 02/09/1993 | CA2074700A1 Isolation and structure of the cell growth inhibitory cycloheptapeptide axinastatin 1 |
| 02/09/1993 | CA2074699A1 Neristatin 1 |
| 02/07/1993 | CA2075343A1 Monoclonal antibody and uses of the same |
| 02/07/1993 | CA2075336A1 3-deoxy-mannosamine derivatives and process for their preparation |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002094A1 A process for the preparation of demethylepypodophyllotoxin |
| 02/04/1993 | WO1993002087A1 Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| 02/04/1993 | WO1993001821A1 Novel glycoside compounds and production and use thereof |
| 02/03/1993 | EP0525992A2 Cluster conjugates of drugs with antibodies |
| 02/03/1993 | EP0525973A2 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 02/03/1993 | EP0525960A1 Use of rapamycin for the treatment of adult T-cell leukemia/lymphoma |
| 02/03/1993 | EP0525938A1 Gallium compounds |
| 02/03/1993 | EP0525917A2 Double-stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
| 02/03/1993 | EP0525570A2 Anti-idiotypic antibodies that mimic TNF |
| 02/03/1993 | EP0525479A1 Spicamycin derivatives and the use thereof |
| 02/03/1993 | EP0525472A2 Methylen-oxindole derivatives and process for their preparation |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525119A1 Antibody conjugates for treatment of neoplastic disease |
| 02/03/1993 | EP0525054A1 Modified heparin binding growth factors |
| 02/03/1993 | EP0525023A1 Novel pyridine esters |
| 02/03/1993 | EP0524997A1 2'-o-alkyl nucleotides and polymers containing them. |
| 02/03/1993 | EP0524974A1 Pyridines as medicaments |
| 02/03/1993 | CN1068570A Antiviral combinations |
| 02/03/1993 | CN1068569A Dithiane |
| 02/02/1993 | US5183884 Novel proteins (erbB-3 gene) of the erB proto-oncogene family; immunoassay; antitumor and -carcinogenic agents |
| 02/02/1993 | US5183882 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
| 02/02/1993 | US5183804 Anticarcinogenic agents |
| 02/02/1993 | US5183667 Treating tumor disease by administering culture product containing beta-glucan |
| 02/02/1993 | CA2092571A1 Ribozyme inhibition of bcr-abl gene expression |
| 02/02/1993 | CA1313372C Polycyclic heterocyclic derivatives, a process for their preparation and their application to veterinary and human medicine |
| 02/01/1993 | CA2074662A1 Anti-idiotypic antibodies that mimic tnf |
| 01/27/1993 | EP0524768A2 Ribotoxins, conjugates thereof ans pharmaceutical composition |
| 01/27/1993 | EP0524742A2 Benzo(a)fluorene compounds |
| 01/27/1993 | EP0524639A2 Process for the labelling of substances with technetium or rhenium |
| 01/27/1993 | EP0524633A2 Pharmaceutical composition suitable for influencing the reticuloendothelial system |
| 01/26/1993 | US5182273 Spirocyclic n, o derivatives of cyclotriphosphazenes and their use in therapy |
| 01/26/1993 | CA1313157C Gastrin releasing peptide antagonist |
| 01/25/1993 | CA2070751A1 Proteins |
| 01/23/1993 | CA2073488A1 Benzo (a) fluorene compounds |
| 01/21/1993 | WO1993001281A1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 01/21/1993 | WO1993001202A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 01/21/1993 | WO1993001201A1 Mono and bis alkylamino-anthracyclines |
| 01/21/1993 | WO1993001182A1 Methylen-oxindole derivatives and process for their preparation |
| 01/21/1993 | WO1993001167A1 Pyrrolidine and thiazolidine derivatives, preparation thereof and drugs containing same |
| 01/21/1993 | WO1993000929A1 Novel compositions based on taxane class derivatives |
| 01/21/1993 | WO1993000928A1 Novel compositions based on taxane class derivatives |
| 01/21/1993 | WO1993000927A1 Cancer treatment |
| 01/21/1993 | WO1993000918A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 01/21/1993 | WO1993000909A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | CA2112799A1 Method and assay system for neurotrophin activity |
| 01/21/1993 | CA2111564A1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 01/20/1993 | EP0523873A1 Non-substrate peptide inhibitors of farnesyl protein transferase |
| 01/20/1993 | EP0523845A2 New benzodiazepine analogs |
| 01/20/1993 | EP0523493A1 Dithianes |
| 01/20/1993 | EP0523395A2 Seroreactive domains from the HPV 16 E1 and E2 proteins |
| 01/20/1993 | CN1068119A Octadecyl(2-(n-methyl-priperidino)-ethyl)-phosphate and process for its preparation |
| 01/19/1993 | US5180820 Nucleic acid sequence code |